Patient-reported outcome measures assessing depression symptom severity and clinical status are sent via the national secure mail platform at three time points: 6, 12 and 18 months after treatment start (Table 4). Complete registry follow-up is done at 18 months as well.
Follow-up Measurements aOmitted if the patient did not receive antidepressant medication
Measures
6 months
12 months
18 months
Quick Inventory of Depressive Symptomatology (QIDS-SR)
X
X
X
BSI-18, SCL-10, WHO-5 and mSDS
X
X
X
Patient-Reported Inventory of Side-Effects (PRISE)[51]a
Jensen K.H., Dam V.H., Ganz M., Fisher P.M., Ip C.T., Sankar A., Marstrand-Joergensen M.R., Ozenne B., Osler M., Penninx B.W., Pinborg L.H., Frokjaer V.G., Knudsen G.M, & Jørgensen M.B. (2023). Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort. BMC Psychiatry, 23, 151.
Publication 2023
After treatmentAntidepressantDepression symptomPatient
Quick Inventory of Depressive Symptomatology (QIDS-SR)
BSI-18, SCL-10, WHO-5 and mSDS
Patient-Reported Inventory of Side-Effects (PRISE)
Negative Effects Questionnaire (NEQ)
control variables
Control variables not explicitly mentioned.
controls
No positive or negative controls are specified in the provided information.
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required